Many tumours of the skull base, including schwannomas, paragangliomas,
meningiomas and anterior pituitary tumours occur both as sporadic tum
ours and in clear cut familial syndromes. These cancers' highly penetr
ant dominantly inherited syndromes have proven to be a rich resource f
or locating tumour genes, most of which are of the tumour suppressor t
ype. Recently, the gene for type 2 neurofibromatosis (NF2) was isolate
d by the technique of positional cloning. The NF2 gene has now been de
monstrated to be involved in the pathogenesis of both familial and non
-familial vestibular schwannomas as well as meningiomas. The presence
of inactivating mutations within this gene suggests that it acts as a
tumour suppressor and the mechanism has been shown to comply with a 't
wo hit' mutation model. Hereditary tumours constitute a small proporti
on of all cases, but evidence from studies of tumours such as vestibul
ar schwannoma and meningioma have shown that their genes are also rele
vant to the much more common non-familial forms of the same tumour. Th
is paper briefly describes the approach to locating tumour genes, and
reviews our current knowledge regarding the chromosomal location and f
unction of genes responsible for familial tumours involving the skull
base. The genetic mechanisms of tumourigenesis are discussed as are th
e prospects for the development of novel forms of diagnosis and treatm
ent.